Results 11 to 20 of about 40,122 (251)
Efficiency and safety of pharmacological cardioversion for atrial fibrillation
Клинический разбор в общей медицине, 2021 Currently, atrial fibrillation is the most prevalent supraventricular tachycardia. Selection of management strategy for such patients becomes an important issue for medical practitioners.
Aleksei V. Tarasov
doaj +2 more sources
Leadless Pacing and Cardioversion: Power On or Power Off? [PDF]
JACC Case RepTilz R, Nikorowitsch J, Traub A.
europepmc +2 more sources
Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients. [PDF]
PLoS ONE, 2018 The relative efficacy of antiarrhythmic drugs (AADs) after electrical cardioversion are not well established. This study aimed to investigate the efficacies of different AADs for maintaining sinus rhythm (SR) after electrical cardioversion for atrial ...
Hye Bin Gwag +6 more
doaj +1 more source
Open Heart, 2021 Introduction Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide. Direct current cardioversion is commonly used to restore sinus rhythm in patients with AF.
David Ferreira +11 more
doaj +1 more source
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study. [PDF]
PLoS ONE, 2015 Cardioversion can rapidly and effectively restore sinus rhythm in patients with persistent atrial fibrillation. Since 2011 dabigatran has been available as an alternative to warfarin to prevent thromboembolic events in patients with non-valvular atrial ...
Jannik Langtved Pallisgaard +7 more
doaj +1 more source
Cardioverting acute atrial fibrillation and the risk of thromboembolism: not all patients are created equal [PDF]
, 2017 Current guidelines support the well-established clinical practice that patients who present with atrial fibrillation (AF) of less than 48 hours duration should be considered for cardioversion, even in the absence of pre-existing anticoagulation. However,
Rankin, Alastair J., Rankin, Stephen H.
core +1 more source
Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial. [PDF]
, 2020 Introduction This X-VeRT (eXplore the efficacy and safety of once-daily oral riVaroxaban for the prevention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion) substudy evaluated the effects of ...
Camm, AJ +9 more
core +1 more source
Рациональная фармакотерапия в кардиологии, 2016 Aim. To study efficacy and safey of sinus rhythm restoration with amiodarone and propafenone in outpatients with recurrent atrial fibrillation (AF), and to estimate pharmacoeconomic efficiency of such cardioversion in comparison with hospital treatment ...
T. A. Istomina +6 more
doaj +1 more source
Heliyon, 2023 This report highlights the feasibility of electrical cardioversion intervention for the treatment of heat stroke complicated by rapid atrial fibrillation.
Wei Wang +3 more
doaj +1 more source
Cardiology Research, 2014 Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. Cardioversion for AF may be performed by either using direct current (DC) shock (electrical cardioversion) or using drugs (chemical cardioversion). Here we report a case of a patient with heart failure and AF, who reverted to the normal sinus rhythm on correction of ...
Theodore, Joseph +4 more
openaire +3 more sources